Close
Nordic 9Nordic 9

Cinference (private company)

Germany cinference.bio
See something wrong or missing? Let us know
Offices:Berlin
Industry:BiotechPharma
Business model:B2B

Cinference is a biotech startup from Germany that uses deep learning to design de novo protein therapies instead of discovering them in a costly and lengthy experimental process.

Investors: we tracked 2 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Cinference

Name Criteria
France AbolerIS Pharma
45%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
Spain Accure Therapeutics
45%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
Sweden Athera
45%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
Sweden AttgeNO
45%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
Sweden Cinclus Pharma
45%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
Denmark Oui
45%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
Finland Desentum
45%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
Sweden Gradientech
45%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
Denmark NMD Pharma
45%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
Sweden OxThera
45%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
Top